L&K BIOMED Co., Ltd. (156100) Price & Analysis

― Followers

156100 Stock Chart & Stats

₩3895.00

-₩90.00(-2.26%)

Jul 29, 2026

―

Day’s Range― - ―

52-Week Range₩3,620.00 - ₩16,400.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)121.44K

Market Cap

₩89.07B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.52

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding22,351,152

10 Day Avg. Volume130,123

30 Day Avg. Volume121,437

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

156100 FAQ

What was L&K BIOMED Co., Ltd.’s price range in the past 12 months?

L&K BIOMED Co., Ltd. lowest stock price was ₩3620.00 and its highest was ₩16400.00 in the past 12 months.

What is L&K BIOMED Co., Ltd.’s market cap?

L&K BIOMED Co., Ltd.’s market cap is ₩89.07B.

When is L&K BIOMED Co., Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were L&K BIOMED Co., Ltd.’s earnings last quarter?

L&K BIOMED Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩374.035 earnings per share for the quarter, beating the consensus estimate of N/A by ₩374.035.

Is L&K BIOMED Co., Ltd. overvalued?

According to Wall Street analysts L&K BIOMED Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does L&K BIOMED Co., Ltd. pay dividends?

L&K BIOMED Co., Ltd. does not currently pay dividends.

What is L&K BIOMED Co., Ltd.’s EPS estimate?

L&K BIOMED Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does L&K BIOMED Co., Ltd. have?

L&K BIOMED Co., Ltd. has 22,351,152 shares outstanding.

What happened to L&K BIOMED Co., Ltd.’s price movement after its last earnings report?

L&K BIOMED Co., Ltd. reported an EPS of ₩374.035 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.56%.

Which hedge fund is a major shareholder of L&K BIOMED Co., Ltd.?

Currently, no hedge funds are holding shares in KR:156100

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology